Selene Veerman

631 total citations
14 papers, 258 citations indexed

About

Selene Veerman is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Selene Veerman has authored 14 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 4 papers in Biological Psychiatry and 3 papers in Pharmacology. Recurrent topics in Selene Veerman's work include Schizophrenia research and treatment (12 papers), Tryptophan and brain disorders (4 papers) and Treatment of Major Depression (3 papers). Selene Veerman is often cited by papers focused on Schizophrenia research and treatment (12 papers), Tryptophan and brain disorders (4 papers) and Treatment of Major Depression (3 papers). Selene Veerman collaborates with scholars based in Netherlands, United States and United Kingdom. Selene Veerman's co-authors include Peter F.J. Schulte, Lieuwe de Haan, Justin D. Smith, Martin Begemann, Dan Cohen, Jan Bogers, J.B. Deijen, Egbert Bakker, Iris E. Sommer and Shiral S. Gangadin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Schizophrenia Bulletin.

In The Last Decade

Selene Veerman

12 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selene Veerman Netherlands 9 170 77 51 44 38 14 258
Yosuke Koshikawa Japan 10 97 0.6× 51 0.7× 38 0.7× 60 1.4× 37 1.0× 25 249
M. Debelle Hungary 6 310 1.8× 50 0.6× 80 1.6× 41 0.9× 84 2.2× 13 381
Judit Harsányi Hungary 7 322 1.9× 63 0.8× 74 1.5× 44 1.0× 88 2.3× 15 422
Erzsébet Szalai Hungary 7 332 2.0× 66 0.9× 73 1.4× 48 1.1× 96 2.5× 12 446
Shiral S. Gangadin Netherlands 10 117 0.7× 63 0.8× 85 1.7× 29 0.7× 39 1.0× 27 260
A. Méary France 7 209 1.2× 37 0.5× 27 0.5× 70 1.6× 55 1.4× 9 315
A. Hasan Germany 9 157 0.9× 33 0.4× 32 0.6× 18 0.4× 27 0.7× 15 244
Inge Winter-van Rossum Netherlands 8 124 0.7× 65 0.8× 17 0.3× 17 0.4× 17 0.4× 16 210
Alejandro Ballesteros Spain 10 174 1.0× 56 0.7× 15 0.3× 20 0.5× 21 0.6× 26 283
James E. Emanuel United States 8 177 1.0× 22 0.3× 27 0.5× 33 0.8× 25 0.7× 12 300

Countries citing papers authored by Selene Veerman

Since Specialization
Citations

This map shows the geographic impact of Selene Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selene Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selene Veerman more than expected).

Fields of papers citing papers by Selene Veerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selene Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selene Veerman. The network helps show where Selene Veerman may publish in the future.

Co-authorship network of co-authors of Selene Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Selene Veerman. A scholar is included among the top collaborators of Selene Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selene Veerman. Selene Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schaefer, Martin, Dragana Bugarski‐Kirola, Mujeeb U. Shad, et al.. (2025). Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials. Clinical Drug Investigation. 45(9). 627–642.
2.
Veerman, Selene, et al.. (2024). Clozapine/norclozapine plasma level ratio and cognitive functioning in patients with schizophrenia spectrum disorders: a systematic review. SHILAP Revista de lepidopterología. 14. 1957219915–1957219915.
3.
Schulte, Peter F.J., et al.. (2023). Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?. Schizophrenia Research. 268. 74–81. 4 indexed citations
4.
Veerman, Selene, et al.. (2022). Clozapine and COVID‐19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study. Acta Psychiatrica Scandinavica. 146(2). 168–178. 15 indexed citations
5.
Sommer, Iris E., Shiral S. Gangadin, Lot D. de Witte, et al.. (2021). Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial. Schizophrenia Bulletin. 47(4). 1108–1115. 25 indexed citations
6.
Veerman, Selene, Jan Bogers, Dan Cohen, & Peter F.J. Schulte. (2021). COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine. Pharmacopsychiatry. 55(1). 48–56. 14 indexed citations
7.
Veerman, Selene, Peter F.J. Schulte, & Lieuwe de Haan. (2017). Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review. Drugs. 77(13). 1423–1459. 57 indexed citations
8.
Veerman, Selene. (2017). Pharmacological interventions in clozapine-refractory schizophrenia. UvA-DARE (University of Amsterdam). 1 indexed citations
9.
Veerman, Selene, Peter F.J. Schulte, Justin D. Smith, & Lieuwe de Haan. (2016). Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study. Psychological Medicine. 46(9). 1909–1921. 54 indexed citations
10.
Veerman, Selene, Peter F.J. Schulte, J.B. Deijen, & Lieuwe de Haan. (2016). Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study. Psychological Medicine. 47(2). 363–375. 17 indexed citations
11.
Veerman, Selene, Peter F.J. Schulte, & Lieuwe de Haan. (2014). The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged. Pharmacopsychiatry. 47(04/05). 121–130. 26 indexed citations
12.
Veerman, Selene, et al.. (2014). Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis. Pharmacopsychiatry. 47(6). 185–194. 29 indexed citations
13.
Veerman, Selene, Peter F.J. Schulte, Martin Begemann, & Lieuwe de Haan. (2014). Non-Glutamatergic Clozapine Augmentation Strategies: A Review and Meta-Analysis. Pharmacopsychiatry. 47(7). 231–238. 14 indexed citations
14.
Veerman, Selene, et al.. (2010). [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].. PubMed. 52(6). 411–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yosuke Koshikawa Breakdown of academic impact, for papers by M. Debelle Breakdown of academic impact, for papers by Judit Harsányi Breakdown of academic impact, for papers by Erzsébet Szalai Breakdown of academic impact, for papers by Shiral S. Gangadin Breakdown of academic impact, for papers by A. Méary Breakdown of academic impact, for papers by A. Hasan Breakdown of academic impact, for papers by Inge Winter-van Rossum Breakdown of academic impact, for papers by Alejandro Ballesteros Breakdown of academic impact, for papers by James E. Emanuel
Rankless by CCL
2026